The Effect of Acupuncture on Pain, Prostaglandin E2, and Interleukin-6 in Septorhinoplasty Operations: A Randomized Clinical Trial

针灸对鼻中隔成形术中疼痛、前列腺素E2和白细胞介素-6的影响:一项随机临床试验

阅读:1

Abstract

OBJECTIVE: The purpose of this study was to investigate the effects of acupuncture on pain, prostaglandin E2 (PGE2), and interleukin-6 (IL-6) levels during septorhinoplasty surgeries. MATERIALS AND METHODS: This randomized, controlled study included 70 patients. The patients were divided into two groups: an acupuncture group (n = 35) and a control group (n = 35). The acupuncture group received bilateral press needle acupuncture at the PC 6 and ST 36 points 24 h before surgery. Blood samples were collected for analysis and comparison of preoperative and postoperative levels of IL-6 and PGE2. The primary outcomes were the postoperative visual analog scale (VAS) scores. RESULTS: In terms of evaluating postoperative pain, no statistically significant differences were observed between the study groups with regard to VAS scores. At 30 min after surgery, fewer patients in the acupuncture group needed analgesics than in the control group (p = 0.044). Postoperative IL-6 levels were lower in the acupuncture group than in the control group (p = 0.014). There was no significant difference in postoperative PGE2 levels between the groups (p = 0.568). The acupuncture group had lower diastolic blood pressure (DBP) and mean arterial blood pressure (MAP) at 30 min intraoperatively and lower DBP at 60 min (p = 0.012, p = 0.026, and p = 0.012, respectively). At 15 min into the operation, the heart rate was higher in the acupuncture group than in the control group (p = 0.039). After surgery, the acupuncture group had lower blood pressure at 5 min and 6 h after surgery than the control group (p = 0.034 and p = 0.041, respectively). CONCLUSIONS: The evidence from this study suggests that acupuncture can reduce the need for pain medication after septorhinoplasty surgery, and by decreasing IL-6 levels, it may contribute to the inflammatory process. TRIAL REGISTRATION: ClinicalTrials.gov: NCT04009070.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。